Air classifier technology (ACT) in dry powder inhalation. Part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier on adhesive mixtures
- PMID: 12842339
- DOI: 10.1016/s0378-5173(03)00250-3
Air classifier technology (ACT) in dry powder inhalation. Part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier on adhesive mixtures
Abstract
Air classifier technology (ACT) is introduced as part of formulation integrated dry powder inhaler development (FIDPI) to optimise the de-agglomeration of inhalation powders. Carrier retention and de-agglomeration results obtained with a basic classifier concept are discussed. The theoretical cut-off diameter for lactose of the classifier used, is between 35 and 15 microm for flow rates ranging from 20 to 70 l/min. Carrier retention of narrow size fractions is higher than 80% for flow rates between 30 and 60 l/min, inhalation times up to 6s and classifier payloads between 0 and 30mg. The de-agglomeration efficiency for adhesive mixtures, derived from carrier residue (CR) measurement, increases both with increasing flow rate and inhalation time. At 30 l/min, 60% fine particle detachment can be obtained within 3s circulation time, whereas at 60 l/min only 0.5s is necessary to release more than 70%. More detailed information of the change of detachment rate within the first 0.5s of inhalation is obtained from laser diffraction analysis (LDA) of the aerosol cloud. The experimental results can be explained with a novel force distribution concept (FDC) which is introduced to better understand the complex effects of mixing and inhalation parameters on the size distributions of adhesion and removal forces and their relevance to the de-agglomeration in the classifier.
Similar articles
-
Air classifier technology (ACT) in dry powder inhalation. Part 2. The effect of lactose carrier surface properties on the drug-to-carrier interaction in adhesive mixtures for inhalation.Int J Pharm. 2003 Jul 24;260(2):201-16. doi: 10.1016/s0378-5173(03)00264-3. Int J Pharm. 2003. PMID: 12842340
-
Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.Int J Pharm. 2006 Mar 9;310(1-2):81-9. doi: 10.1016/j.ijpharm.2005.11.029. Epub 2006 Jan 25. Int J Pharm. 2006. PMID: 16442246
-
Air classifier technology (ACT) in dry powder inhalation Part 3. Design and development of an air classifier family for the Novolizer multi-dose dry powder inhaler.Int J Pharm. 2006 Mar 9;310(1-2):72-80. doi: 10.1016/j.ijpharm.2005.11.030. Epub 2006 Jan 25. Int J Pharm. 2006. PMID: 16442248
-
The role of particle properties in pharmaceutical powder inhalation formulations.J Aerosol Med. 2002 Fall;15(3):325-30. doi: 10.1089/089426802760292672. J Aerosol Med. 2002. PMID: 12396421 Review.
-
Lactose characteristics and the generation of the aerosol.Adv Drug Deliv Rev. 2012 Mar 15;64(3):233-56. doi: 10.1016/j.addr.2011.05.003. Epub 2011 May 13. Adv Drug Deliv Rev. 2012. PMID: 21616107 Review.
Cited by
-
Targeting the small airways with dry powder adenosine: a challenging concept.Eur Clin Respir J. 2017 Sep 6;4(1):1369328. doi: 10.1080/20018525.2017.1369328. eCollection 2017. Eur Clin Respir J. 2017. PMID: 29057065 Free PMC article.
-
Agglomerated novel spray-dried lactose-leucine tailored as a carrier to enhance the aerosolization performance of salbutamol sulfate from DPI formulations.Drug Deliv Transl Res. 2018 Dec;8(6):1769-1780. doi: 10.1007/s13346-017-0462-8. Drug Deliv Transl Res. 2018. PMID: 29260462 Free PMC article.
-
Studies on the effect of the size of polycaprolactone microspheres for the dispersion of salbutamol sulfate from dry powder inhaler formulations.Pharm Res. 2012 Sep;29(9):2445-55. doi: 10.1007/s11095-012-0772-y. Epub 2012 May 15. Pharm Res. 2012. PMID: 22584947
-
Understanding Carrier Performance in Low-Dose Dry Powder Inhalation: An In Vitro-In Silico Approach.Pharmaceutics. 2021 Feb 24;13(3):297. doi: 10.3390/pharmaceutics13030297. Pharmaceutics. 2021. PMID: 33668317 Free PMC article.
-
New mechanisms to explain the effects of added lactose fines on the dispersion performance of adhesive mixtures for inhalation.PLoS One. 2014 Jan 28;9(1):e87825. doi: 10.1371/journal.pone.0087825. eCollection 2014. PLoS One. 2014. PMID: 24489969 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources